Early Onset Alzheimer’s
Early Onset Alzheimer’s: At our clinic, we approach the whole person and not just their brain.
Early Onset Alzheimer’s: Alzheimer’s Disease is a family of brain disorders usually found in elderly patients and is the most common cause of dementia. It is characterised by slow, progressive loss of brain function, notable lapses in memory, disorientation, confusion, mood swings, changes in personality. There are language problems, such as difficulty in finding the right words for everyday objects, loss of behavioural inhibitions and motivation and paranoia.
The course of Alzheimer’s varies widely. The duration of illness can range from just a few years to over 20 years. During this time the parts of the brain that control memory and thinking are amongst the first to be affected, followed by other brain changes that ultimately result in brain cell death.
Alzheimer’s is characterised by distinct changes in brain tissues and cells. Amongst the most notable are the appearance of plaques and tangles of neurofibrils within brain nerve cells that affect junctions between nerve cells (synapses) and nerve to nerve cell communication. These structural alterations involve the formation and depositing amyloid plaques. So are the plaques a defence against infection? This has been suggested by researchers, who have found a bacterium in each plaque.
Recently Alzheimer’s Disease brain infections, both viral and bacterial, have become important. Several infections have attracted considerable attention and some have been found at high incidence in the brains of Alzheimer’s patients. The presence of infections in Alzheimer’s patients has been proposed to be a primary event in the formation of Alzheimer’s amyloid plaques.
It has been proposed that such infections may act as a trigger in Alzheimer’s Disease. Study authors also stressed that systemic infections must be considered as potential contributors to the development of Alzheimer’s.
At Harley Street IBS & Autoimmune Clinic, we aim to diagnose the underlying issues of early onset Alzheimer’s. In our treatment for early onset Alzheimer’s, a plan is formulated once we have the test results – using a Functional Medicine approach along with natural medicine.
Lane CA, Hardy J, Schott JM.
Eur J Neurol. 2018 Jan;25(1):59-70. doi: 10.1111/ene.13439. Epub 2017 Oct 19.
PMID: 28872215 Review.
Alzheimer’s disease, the commonest cause of dementia, is a growing global health concern with huge implications for individuals and society. In this review, current understanding of the epidemiology, genetics, pathology and pathogenesis of Alzheimer’ …
2016 Alzheimer’s disease facts and figures.
Alzheimers Dement. 2016 Apr;12(4):459-509. doi: 10.1016/j.jalz.2016.03.001.
The actual number of deaths to which Alzheimer’s disease contributes is likely much larger than the number of deaths from Alzheimer’s disease recorded on death certificates. In 2016, an estimated 700,000 Americans age ≥ 65 years will die …
Drug treatments in Alzheimer’s disease.
Briggs R, Kennelly SP, O’Neill D.
Clin Med (Lond). 2016 Jun;16(3):247-53. doi: 10.7861/clinmedicine.16-3-247.
PMID: 27251914 Free PMC article. Review.
Despite the significant public health issue that it poses, only five medical treatments have been approved for Alzheimer’s disease (AD) and these act to control symptoms rather than alter the course of the disease. Studies of potential disease-m …
Ugeskr Laeger. 2017 Mar 20;179(12):V09160686.
PMID: 28330540 Review. Danish.
Alzheimer’s disease is a neurodegenerative disorder with insidious onset and slow progression. Prevalence is increasing, although not as fast as previously believed. …Application of these methods increases, partly due to improved awareness of cognitive symp …
Alzheimer’s Disease: Past, Present, and Future.
Bondi MW, Edmonds EC, Salmon DP.
J Int Neuropsychol Soc. 2017 Oct;23(9-10):818-831. doi: 10.1017/S135561771700100X.
PMID: 29198280 Free PMC article. Review.
Since then we have witnessed an explosion of basic and translational research into the causes, characterizations, and possible treatments for Alzheimer’s disease (AD) and other dementias. We review this lineage of work beginning with Alzheimer’s …
NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease.
Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Sperling R; Contributors.
Alzheimers Dement. 2018 Apr;14(4):535-562. doi: 10.1016/j.jalz.2018.02.018.
PMID: 29653606 Free PMC article. Review.
In 2011, the National Institute on Aging and Alzheimer’s Association created separate diagnostic recommendations for the preclinical, mild cognitive impairment, and dementia stages of Alzheimer’s disease. …In the National Institute on Aging an …
If you would like to try this natural approach to early onset Alzheimer’sContact Deborah’s Medical Secretary for an appointment